dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:21:06Z
dc.date.accessioned2022-10-05T17:53:12Z
dc.date.available2014-05-27T11:21:06Z
dc.date.available2022-10-05T17:53:12Z
dc.date.created2014-05-27T11:21:06Z
dc.date.issued2004-07-01
dc.identifierPesquisa odontologica brasileira = Brazilian oral research, v. 18, n. 3, p. 197-201, 2004.
dc.identifier1806-8324
dc.identifierhttp://hdl.handle.net/11449/67790
dc.identifier10.1590/S1806-83242004000300004
dc.identifierS1806-83242004000300004
dc.identifier2-s2.0-28744439106
dc.identifier2-s2.0-28744439106.pdf
dc.identifier0322020541055900
dc.identifier0053567153623569
dc.identifier6543563161403421
dc.identifier0000-0002-2416-2173
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3917402
dc.description.abstractThe aim of this study was to observe the prevalence of Candida spp. in the oral cavity of children undergoing treatment with inhaled corticosteroids. Thirty children treated with inhaled corticosteroids and thirty control children were studied. Saliva samples were collected through oral rinses with phosphate buffered saline (PBS). The samples were plated on Sabouraud's dextrose agar and incubated at 37 degrees C for 48 h. After this period, the number of colony-forming units per ml (cfu/ml) of saliva was calculated. The isolates were identified by phenotypic characterization. Candida spp. was isolated from 43.33% of the samples of children treated with corticosteroids, with a mean of 780 cfu/ml of saliva, and from 30% of the samples of the control group, with a mean of 560 cfu/ml of saliva. No significant statistical difference was observed between the groups. C. albicans was the prevalent species in both groups, followed by C. guilliermondii, C. parapsilosis and C. stellatoidea. Furthermore, Rhodotorula rubra and C. lusitaniae were also isolated from the treated group. We concluded that there was no significant increase in the prevalence and number of Candida spp. in the oral cavity of children treated with inhaled corticosteroids.
dc.languageeng
dc.relationPesquisa Odontológica Brasileira = Brazilian Oral Research
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectcorticosteroid
dc.subjectasthma
dc.subjectbacterial count
dc.subjectCandida
dc.subjectcase control study
dc.subjectchild
dc.subjectclassification
dc.subjecthuman
dc.subjectinhalational drug administration
dc.subjectisolation and purification
dc.subjectmicrobiology
dc.subjectpreschool child
dc.subjectprevalence
dc.subjectsaliva
dc.subjectAdministration, Inhalation
dc.subjectAdrenal Cortex Hormones
dc.subjectAsthma
dc.subjectCase-Control Studies
dc.subjectChild
dc.subjectChild, Preschool
dc.subjectColony Count, Microbial
dc.subjectHumans
dc.subjectPrevalence
dc.subjectSaliva
dc.titlePrevalence of yeasts in the oral cavity of children treated with inhaled corticosteroids
dc.typeArtigo


Este ítem pertenece a la siguiente institución